{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:07:06Z","timestamp":1791025626161,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007743","name":"European Society for Clinical Nutrition","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007743","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.clnu.2013.06.013","type":"journal-article","created":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T05:01:29Z","timestamp":1372222889000},"page":"448-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia"],"prefix":"10.1016","volume":"33","author":[{"given":"Daniel J.","family":"Ham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon S.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clnu.2013.06.013_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1242\/dmm.008839","article-title":"Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia","volume":"5","author":"Murphy","year":"2012","journal-title":"Disease Models Mech"},{"issue":"5","key":"10.1016\/j.clnu.2013.06.013_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clnu.2013.06.013_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pharmthera.2006.11.004","article-title":"Therapeutic approaches for muscle wasting disorders","volume":"113","author":"Lynch","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.clnu.2013.06.013_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0885-3924(03)00074-5","article-title":"Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale","volume":"25","author":"Tranmer","year":"2003","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2013.06.013_bib5","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ejphar.2011.07.007","article-title":"Anti-inflammatory therapies in cancer cachexia","volume":"668","author":"Argil\u00e9s","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.clnu.2013.06.013_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1017\/S0029665110003927","article-title":"Dietary protein and exercise training in ageing","volume":"70","author":"Koopman","year":"2011","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"10.1016\/j.clnu.2013.06.013_bib7","first-page":"247","article-title":"Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice","volume":"26","author":"Peters","year":"2011","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1016\/j.clnu.2013.06.013_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1067\/msy.2001.112594","article-title":"Glycine preserves function and decreases necrosis in skeletal muscle undergoing ischemia and reperfusion injury","volume":"129","author":"Ascher","year":"2001","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.clnu.2013.06.013_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00075197-200303000-00013","article-title":"L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent","volume":"6","author":"Zhong","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"12","key":"10.1016\/j.clnu.2013.06.013_bib10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1053\/meta.2000.18524","article-title":"Intravenous glutamine does not stimulate mixed muscle protein synthesis in healthy young men and women","volume":"49","author":"Zachwieja","year":"2000","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.clnu.2013.06.013_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1","volume":"304","author":"De Luca","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.clnu.2013.06.013_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00421-005-0118-0","article-title":"Intramyocellular lipid and glycogen content are reduced following resistance exercise in untrained healthy males","volume":"96","author":"Koopman","year":"2006","journal-title":"Eur J Appl Physiol"},{"issue":"4","key":"10.1016\/j.clnu.2013.06.013_bib13","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1523\/JNEUROSCI.16-04-01324.1996","article-title":"Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine","volume":"16","author":"Bindokas","year":"1996","journal-title":"J\u00a0Neurosci Official J Soc Neurosci"},{"issue":"5","key":"10.1016\/j.clnu.2013.06.013_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clnu.2007.05.007","article-title":"Immune and cell modulation by amino acids","volume":"26","author":"Roth","year":"2007","journal-title":"Clin Nutr"},{"issue":"6084","key":"10.1016\/j.clnu.2013.06.013_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science.1218595","article-title":"Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation","volume":"336","author":"Jain","year":"2012","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.clnu.2013.06.013_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/carcin\/20.5.793","article-title":"Dietary glycine inhibits the growth of B16 melanoma tumors in mice","volume":"20","author":"Rose","year":"1999","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.clnu.2013.06.013_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1207\/S15327914NC402_17","article-title":"Endothelial cells contain a glycine-gated chloride channel","volume":"40","author":"Yamashina","year":"2001","journal-title":"Nutr Cancer"},{"issue":"1","key":"10.1016\/j.clnu.2013.06.013_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14728214.2012.652946","article-title":"Editorial update on emerging drugs for cancer cachexia","volume":"17","author":"Murphy","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"10.1016\/j.clnu.2013.06.013_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0266-4356(96)90012-1","article-title":"Hand grip strength: an indicator of nutritional state and the mix of postoperative complications in patients with oral and maxillofacial cancers","volume":"34","author":"Guo","year":"1996","journal-title":"Br J Oral Maxillofacial Surg"},{"issue":"1A","key":"10.1016\/j.clnu.2013.06.013_bib20","first-page":"139","article-title":"Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice","volume":"18","author":"Yamamoto","year":"1998","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.clnu.2013.06.013_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1165\/ajrcmb.26.5.4598","article-title":"Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species","volume":"26","author":"Kosmidou","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.clnu.2013.06.013_bib22","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1074\/jbc.M112.419788","article-title":"Interleukin-6\/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration","volume":"288","author":"Zhang","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.clnu.2013.06.013_bib23","doi-asserted-by":"crossref","first-page":"C542","DOI":"10.1152\/ajpcell.00192.2009","article-title":"p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting","volume":"298","author":"McClung","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.clnu.2013.06.013_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3835(02)00006-X","article-title":"Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress","volume":"180","author":"Gomes-Marcondes","year":"2002","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.clnu.2013.06.013_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00075197-200501000-00007","article-title":"Skeletal muscle glutamate metabolism in health and disease: state of the art","volume":"8","author":"Rutten","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnu.2013.06.013_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/cells1030325","article-title":"Autophagy in skeletal muscle homeostasis and in muscular dystrophies","volume":"1","author":"Grumati","year":"2012","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.clnu.2013.06.013_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.clnu.2013.06.013_bib28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/emboj.2008.52","article-title":"The initiation factor eIF3-f is a major target for atrogin1\/MAFbx function in skeletal muscle atrophy","volume":"27","author":"Lagirand-Cantaloube","year":"2008","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.clnu.2013.06.013_bib29","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1152\/ajpendo.00060.2012","article-title":"Role of IGF-I and the TNFalpha\/NF-kappaB pathway in the induction of muscle atrogenes by acute inflammation","volume":"303","author":"Schakman","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561413001854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561413001854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:19:49Z","timestamp":1588958389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561413001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0261561413001854"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2013.06.013","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2013.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}